256 related articles for article (PubMed ID: 26658557)
1. A Two-Day Continuous Nicotine Infusion Is Sufficient to Demonstrate Nicotine Withdrawal in Rats as Measured Using Intracranial Self-Stimulation.
Muelken P; Schmidt CE; Shelley D; Tally L; Harris AC
PLoS One; 2015; 10(12):e0144553. PubMed ID: 26658557
[TBL] [Abstract][Full Text] [Related]
2. Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine.
Harris AC; Manbeck KE; Schmidt CE; Shelley D
Psychopharmacology (Berl); 2013 Jan; 225(2):291-302. PubMed ID: 22868410
[TBL] [Abstract][Full Text] [Related]
3. Similar precipitated withdrawal effects on intracranial self-stimulation during chronic infusion of an e-cigarette liquid or nicotine alone.
Harris AC; Muelken P; Smethells JR; Krueger M; LeSage MG
Pharmacol Biochem Behav; 2017 Oct; 161():1-5. PubMed ID: 28867606
[TBL] [Abstract][Full Text] [Related]
4. Further pharmacological characterization of a preclinical model of the early development of nicotine withdrawal.
Harris AC
Drug Alcohol Depend; 2021 Sep; 226():108870. PubMed ID: 34216863
[TBL] [Abstract][Full Text] [Related]
5. Effects of oxytocin on nicotine withdrawal in rats.
Manbeck KE; Shelley D; Schmidt CE; Harris AC
Pharmacol Biochem Behav; 2014 Jan; 116():84-9. PubMed ID: 24239789
[TBL] [Abstract][Full Text] [Related]
6. Magnitude of open-field thigmotaxis during mecamylamine-precipitated nicotine withdrawal in rats is influenced by mecamylamine dose, duration of nicotine infusion, number of withdrawal episodes, and age.
Harris AC
Pharmacol Biochem Behav; 2021 Jun; 205():173185. PubMed ID: 33831460
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in the reward deficit and somatic signs associated with precipitated nicotine withdrawal in rats.
Tan S; Xue S; Behnood-Rod A; Chellian R; Wilson R; Knight P; Panunzio S; Lyons H; Febo M; Bruijnzeel AW
Neuropharmacology; 2019 Dec; 160():107756. PubMed ID: 31487496
[TBL] [Abstract][Full Text] [Related]
8. Withdrawal from repeated nicotine vapor exposure increases somatic signs of physical dependence, anxiety-like behavior, and brain reward thresholds in adult male rats.
Martínez M; Espinoza VE; Garcia V; Uribe KP; Negishi K; Estevao IL; Carcoba LM; O'Dell LE; Khan AM; Mendez IA
Neuropharmacology; 2023 Dec; 240():109681. PubMed ID: 37611823
[TBL] [Abstract][Full Text] [Related]
9. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.
Watkins SS; Stinus L; Koob GF; Markou A
J Pharmacol Exp Ther; 2000 Mar; 292(3):1053-64. PubMed ID: 10688623
[TBL] [Abstract][Full Text] [Related]
10. Null mutation of the β2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in mice.
Stoker AK; Marks MJ; Markou A
Eur J Pharmacol; 2015 Apr; 753():146-50. PubMed ID: 25107281
[TBL] [Abstract][Full Text] [Related]
11. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.
Paterson NE; Markou A
Psychopharmacology (Berl); 2004 Apr; 173(1-2):64-72. PubMed ID: 14712336
[TBL] [Abstract][Full Text] [Related]
12. Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.
Stoker AK; Olivier B; Markou A
Behav Genet; 2012 May; 42(3):423-36. PubMed ID: 22009521
[TBL] [Abstract][Full Text] [Related]
13. Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies.
Johnson PM; Hollander JA; Kenny PJ
Pharmacol Biochem Behav; 2008 Sep; 90(3):409-15. PubMed ID: 18466962
[TBL] [Abstract][Full Text] [Related]
14. Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.
Skjei KL; Markou A
Psychopharmacology (Berl); 2003 Jul; 168(3):280-92. PubMed ID: 12712232
[TBL] [Abstract][Full Text] [Related]
15. Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.
Stoker AK; Olivier B; Markou A
Psychopharmacology (Berl); 2012 May; 221(2):317-27. PubMed ID: 22147259
[TBL] [Abstract][Full Text] [Related]
16. Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats.
Yamada H; Bishnoi M; Keijzers KF; van Tuijl IA; Small E; Shah HP; Bauzo RM; Kobeissy FH; Sabarinath SN; Derendorf H; Bruijnzeel AW
Pharmacol Biochem Behav; 2010 Jun; 95(4):401-9. PubMed ID: 20211642
[TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with the vasopressin 1b receptor antagonist SSR149415 prevents the dysphoria associated with nicotine withdrawal in rats.
Qi X; Guzhva L; Ji Y; Bruijnzeel AW
Behav Brain Res; 2015 Oct; 292():259-65. PubMed ID: 26112757
[TBL] [Abstract][Full Text] [Related]
18. Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar rats.
Shram MJ; Siu EC; Li Z; Tyndale RF; Lê AD
Psychopharmacology (Berl); 2008 Jun; 198(2):181-90. PubMed ID: 18385986
[TBL] [Abstract][Full Text] [Related]
19. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Panagis G; Hildebrand BE; Svensson TH; Nomikos GG
Synapse; 2000 Jan; 35(1):15-25. PubMed ID: 10579804
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.
Jackson A; Papke RL; Damaj MI
Psychopharmacology (Berl); 2018 Jul; 235(7):1897-1905. PubMed ID: 29549391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
